1,3-Dihydroxyadamantane
Product Profile
Apply for Sample| Names | |
|---|---|
| Preferred IUPAC name | adamantane-1,3-diol |
| Other names | Adamantane-1,3-diol 1,3-Adamantanediol |
| Pronunciation | /ˈwʌn θri daɪˈhaɪdrɒksiˌædəˈmænteɪn/ |
| Identifiers | |
| CAS Number | 500-96-9 |
| Beilstein Reference | 1460693 |
| ChEBI | CHEBI:156209 |
| ChEMBL | CHEMBL107118 |
| ChemSpider | 20645477 |
| DrugBank | DB08257 |
| ECHA InfoCard | 100.143.169 |
| EC Number | 206-119-7 |
| Gmelin Reference | 78698 |
| KEGG | C21101 |
| MeSH | D000312 |
| PubChem CID | 6917 |
| RTECS number | KY5775000 |
| UNII | ZKN7F4UJ1J |
| UN number | NA3076 |
| CompTox Dashboard (EPA) | DB11344 |
| Properties | |
| Chemical formula | C10H16O2 |
| Molar mass | 170.24 g/mol |
| Appearance | White crystalline powder |
| Odor | odorless |
| Density | 1.28 g/cm³ |
| Solubility in water | Soluble in water |
| log P | 0.35 |
| Vapor pressure | 0.0000165 mmHg at 25°C |
| Acidity (pKa) | 12.34 |
| Basicity (pKb) | pKb ≈ 4.5 |
| Magnetic susceptibility (χ) | -69.0e-6 cm³/mol |
| Refractive index (nD) | 1.570 |
| Viscosity | 78.3 cP (25 °C) |
| Dipole moment | 2.24 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 222.8 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -604.7 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -7515.7 kJ/mol |
| Hazards | |
| Main hazards | H315; H319 |
| GHS labelling | GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H315, H319 |
| Precautionary statements | P264, P270, P280, P301+P312, P330, P501 |
| NFPA 704 (fire diamond) | 1-1-0 |
| Flash point | 125 °C |
| Autoignition temperature | 395 °C |
| Lethal dose or concentration | LD₅₀ (oral, rat): 3700 mg/kg |
| LD50 (median dose) | LD50 (median dose) = 1000 mg/kg (Rat, Oral) |
| NIOSH | GY5950000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 10 mg/m³ |
Chemical ID: CAS Formula HS Code Database
Product Identification – 1,3-Dihydroxyadamantane
| Attribute | Description | Industrial Commentary |
|---|---|---|
| Product Name / IUPAC Name | 1,3-Dihydroxyadamantane / Adamantane-1,3-diol | Adamantane-1,3-diol is supplied by producers active in the Adamantane derivatives sector, typically to support applications in pharmaceuticals, advanced coatings, and specialty resins. Nomenclature on shipping documents follows IUPAC guidelines or regional chemical regulations; accuracy in naming is necessary for cross-border compliance and end-user specification matching. |
| Chemical Formula | C10H16O2 | Purity assessment by producers relies on NMR, GC-MS, and HPLC, with the molecular formula serving as a primary check against process-related byproducts or incomplete conversion. Formula confirmation remains a routine part of batch release QC; sampled lot-to-lot, especially when introducing new catalyst charges or altering process equipment. |
| Synonyms / Trade Names | 1,3-Adamantanediol, Adamantane-1,3-diol, 1,3-Dihydroxytricyclo[3.3.1.13,7]decane | Trade names and synonyms are dependent on labeling regulations or purchasing specifications. Synonym use can affect import documentation and regulatory review; internal batch records reference both IUPAC and common names to reduce mislabeling in downstream handling. |
| HS Code / Customs Classification | 29062900 | International shipments are generally classified under HS 2906.29 for other oxygen-function organic compounds, with customs officials requiring CAS-based verification for rare or specialty molecules. Classification accuracy directly influences import duty assignment. Manufacturers must update HS categorization in response to regulatory matrix changes, for example, as national codes split out specific derivatives for monitoring or restriction under new export control regimes. |
Manufacturer Technical Practices and Considerations
Raw Material Selection and Process Route
Feedstock is constrained by the availability of high-purity adamantane or structurally analogous cycloalkanes. Feedstock sourcing is tightly linked to regional petrochemical capacity and global supply disruptions, which can influence process economics and contaminant load profile. Production employs functionalization of adamantane using oxidation or hydroxyalkylation routes, selected based on plant hydrotreating assets, catalyst reusability, and environmental permit allowances.
Key Control Points & Impurity Management
Major quality-impacting side-products come from over-oxidation, incomplete dihydroxylation, or cross-contamination from upstream synthetic steps. Finished product testing covers not only residual parent hydrocarbon but also regioisomer identification, since 1,3-regioselectivity proves sensitive to catalyst type and batch conditions. Purification sequences will fluctuate—crystallization vs. column-based—according to downstream purity grades (pharmaceutical vs. industrial, for instance).
Batch Consistency and In-Process Controls
Monitoring includes real-time GC or HPLC to profile conversion yield and track minor byproducts. Final batch decision to release for packing follows both internal standards (typical values set by historical manufacturing reproducibility) and customer-agreed limits. Grade-specific requirements drive the testing panel: pharmaceutical grades demand residual solvent and trace metals screens, while technical grades prioritize bulk physical integrity paired with indicative assays for process-specific trace organics.
HS Code Interpretation and Documentation
Selection of the HS code must reflect the actual alkane core and functionalization—not generic polyols—since misclassification affects customs clearance speed and can trigger penalties. Review of CAS linkages to HS codes is routine at product launch or after a harmonized code update. End-use declarations, if solicited by import authorities, hinge on clarity of product naming and purity statements, not generic descriptors.
1,3-Dihydroxyadamantane: Technical Properties, Manufacturing Process & Safety Guidelines
Physical & Chemical Properties
Physical State & Appearance
1,3-Dihydroxyadamantane typically appears as a white to off-white crystalline solid under ambient conditions. The form and degree of crystallinity fluctuate according to drying protocol, purity, and post-synthesis conditioning. Odor, if detectable, tends to be faint. Melting point primarily varies by grade and residual solvent, with the purest grades displaying a narrower melting range. Boiling and flash points often remain undetermined for this class of polyols due to thermal decomposition at elevated temperatures. Density shifts with packing, compaction, and moisture uptake post-drying.
Chemical Stability & Reactivity
Chemical stability in storage spans from stable to hygroscopic, depending on surface area and ambient relative humidity. Overexposure to strong acids or alkalis, oxidizing agents, or heat increases the risk of degradation, polymerization, or color formation. Sensitivity to atmospheric moisture can lead to gradual clumping or surface discoloration in open storage. Process-grade materials demonstrate greater variability here compared to electronic or pharmaceutical grades.
Solubility & Solution Preparation
Solubility favors polar organic solvents and water. Solution clarity and residue formation depend on impurity profile, pH, and temperature. Grades intended for high-purity applications demand deionized water for reproducible dissolving, while technical grades may tolerate tap or process water with occasional filtration needed. Solution concentration and filterability are checked as part of batch quality verification.
Technical Specifications & Quality Parameters
Specification Table by Grade
Each batch is quality-tested to match specification ranges set by application—these may target purity, melting point, appearance, moisture, ash content, and residual starting material content. Electronic grades hold to stricter impurity caps and narrower physical property windows, while industrial grades allow broader limits.
| Property | Technical Grade | High-purity Grade |
|---|---|---|
| Purity (%) | Typical range; grade-dependent | Higher minimum; application-driven |
| Melting Point (°C) | Wider range; not tightly held | Narrow, near theoretical value |
| Appearance | May show slight coloration | White, no visible color |
| Moisture (%) | Broader spec, process-related | Tight control, verified by Karl Fischer |
Impurity Profile & Limits
Impurity profile reflects synthesis route control and purification depth. Typical impurity classes include residual adamantane derivatives, base or acid byproducts, unreacted starting materials, and trace solvents from recrystallization. Target limits depend on contractual requirements. Release testing screens for both intentionally monitored and route-specific trace impurities.
Test Methods & Standards
Standard release tests involve melting point determination, HPLC/GC chromatographic purity, water content by Karl Fischer, and, for some grades, additional spectroscopic or elemental analysis. Test selection and pass/fail cutoffs take into account customer targets and batch-to-batch historical trends.
Preparation Methods & Manufacturing Process
Raw Materials & Sourcing
Raw material integrity shapes final product quality. Feedstock selection factors in both regional chemical markets and qualification track record. Crude adamantane and hydroxyating agents must meet contamination limits and proof-of-origin documentation, particularly for pharmaceutical and electronic raw material routes.
Synthesis Route & Reaction Mechanism
Hydroxylation of adamantane utilizes selective oxidants or controlled hydration contingent on target grade. Catalyst and solvent selection exert strong influence on reaction yield, impurity spectrum, and process risk profile. Each manufacturing site establishes route-specific optimizations to match downstream purification infrastructure.
Process Control & Purification
Critical control points include reaction temperature, time, feed ratios, pH, and workup method. In-process sampling for residual starting materials, side products, and color is routine. Post-synthesis, the product undergoes repeated washing, crystallization, and, where specified, activated carbon treatment or recrystallization to decrease color and trace organics. Waste stream is monitored due to possible oxidizer or metal catalyst carryover, with remediation protocols enforced per site EHS requirements.
Quality Control & Batch Release
Each batch receives analytical scrutiny for property targets, impurity content, and physical appearance. The final release standard combines internal statistical process control with customer contract specifications. Out-of-spec batches are either reprocessed or designated for secondary market applications, depending on deviation type and customer risk tolerance.
Chemical Reactions & Modification Potential
Typical Reactions
Relevant downstream chemistry centers on substitution at the hydroxyl positions, esterification, etherification, or coupling reactions with isocyanates, acids, or halides. Direct reactions exhibit grade, solvent, and pH sensitivity.
Reaction Conditions
Targeted conversion hinges on controlled temperature profiles, use of phase-transfer catalysts or acid/base catalysis, and solvent polarity. Impurities and side reactions increase with relaxed control, especially in less purified grades. Specific downstream uses dictate catalyst choice and batch workup, with solvent residues monitored in the final product.
Derivatives & Downstream Products
End uses range from crosslinked polymers to specialty pharmaceutical intermediates. Derivative formation often proceeds by functional group activation on the adamantane framework, supported by tight control on unreacted hydroxyl content and minimization of colored byproducts.
Storage & Shelf Life
Storage Conditions
Product stability is sensitive to surface moisture and packaging method. Best practice uses tightly sealed, moisture-barrier containers in a temperature and humidity-controlled area. Grades intended for extended storage or high-purity markets are protected from UV and air by opaque, gas-purged containers.
Container Compatibility
Most polyolefin, glass, and lined steel drums suffice for storage and transport, as long as incompatibility with oxidizing materials and acids is avoided. For pharmaceutical/intermediate grades, only certified containers are considered to prevent unintended leaching or contamination.
Shelf Life & Degradation Signs
Observed shelf life reflects grade, storage protocol, and packaging integrity. Color change, clumping, or increased moisture content typically signals product aging or compromised containment. Regular visual and analytical checks diagnose onset of degradation for stock rotation planning.
Safety & Toxicity Profile
GHS Classification
Global harmonization labeling depends on product impurity profile and intended use case. Material can be classified as low acute hazard for most industrial environments, though specific grades may require additional designation for slight irritation or dust hazard. Product labels, SDS, and transport documents reflect batch-specific assessment.
Hazard & Precautionary Statements
Standard precautions apply for dust-generating solids: prevent formation of airborne particles, avoid inhalation, and minimize skin and eye contact. Recommended handling includes adequate ventilation, use of personal protective equipment, and prompt cleanup of spills to limit slip and exposure risk.
Toxicity Data
Available animal and in vitro data suggest low acute toxicity by oral and dermal routes; users should still apply controls due to limited chronic exposure data. Irritation, if present, correlates with grade purity and dust potential. Finished formulations—especially for pharmaceutical use—must undergo additional toxicological review as usage patterns differ from raw intermediate handling.
Exposure Limits & Handling
Workplace exposure is governed by dust levels, not by specific statutory limits for 1,3-dihydroxyadamantane. Housekeeping, engineering controls, and personal respirators are recommended during bulk handling. Open containers and weighing should be performed in local exhaust or containment to reduce operator dust contact and cross-contamination risk.
Supply Capacity & Commercial Terms – 1,3-Dihydroxyadamantane
Production Capacity & Availability
As a primary manufacturer of 1,3-dihydroxyadamantane, our actual production output is a function of campaign scheduling, reactor availability, and raw material supply reliability. Batch process efficiency stabilizes when raw materials—mainly adamantane and the required oxidizing and hydroxy functionalizing reagents—meet both trace impurity and supply consistency benchmarks. Seasonal variations in raw material procurement and turn-around times for plant maintenance directly affect our available inventory. High-purity and custom-spec grades usually allocate production windows distinct from standard output, influencing sector-specific lead times.
Lead Time & Minimum Order Quantity (MOQ)
Lead times are influenced by plant campaign frequency, analytical queue for batch QC release, and overall demand across verticals. MOQ varies with grade: standard industrial grades enable lower MOQ, while specialty, high-purity, or research grades need a full campaign lot to justify equipment cleaning validation and process isolation. MOQs are reviewed per contract and may be modified for long-term supply agreements.
Packaging Options
Packaging follows material compatibility and purity assurance requirements. Industry-grade 1,3-dihydroxyadamantane typically uses HDPE drums, fiber drums with liner bags, or stainless steel containers if reactivity or contamination risk is a concern. End-use dictates the closure system (airtight, tamper-evident, nitrogen-blanketed). Custom pack sizes are possible for downstream integration or pilot projects, with all packaging configurations undergoing compatibility and leaching studies for the highest grades.
Shipping & Payment Terms
Transport method selection aligns with both regulatory and product stability demands, with preference for land-sea intermodal for high-volume contracts and air freight for time-critical, small-batch shipments. Payment terms default to T/T; L/C and other credit terms require credit vetting and may reflect prior transaction history. Incoterms selection is discussed at quotation.
Pricing Structure & Influencing Factors
Raw Material Cost Composition & Fluctuation Causes
Raw material cost remains the primary price driver. Adamantane, produced from petroleum-derived feedstock, is subject to both crude oil volatility and specialty intermediate supply constraints. Oxidants and hydroxy-functionalizing agents, especially when using high-selectivity catalytic routes, impose cost premiums that swing with global chemical commodity prices. Purification and controlled crystallization steps scale non-linearly with purity specification, increasing utility and consumable usage for high-grade material.
Factors Causing Raw Material Price Fluctuations
Supply-demand imbalances for precursor chemicals, geopolitical disruptions, or regulatory changes in regions (particularly affecting China and India) disrupt price stability. Tightening of environmental controls around hazardous intermediates and energy-intensive synthetic steps has created cost spikes. Strategic raw material inventory management and supplier diversification (multiple-country sourcing) offer partial mitigation but not total insulation.
Product Price Difference Explanation: Grade, Purity, Packaging, Certification
Customers specify grades defined by target purity and impurity profile, often validated by chromatographic and crystallographic controls. Higher purity grades command significant premium due not only to extended purification and analytical release time but also to custom packaging or ISO/GMP certification requirements. Application-linked certification—REACH for EU, K-REACH for Korea, chemical registration in Japan—further tightens lot screening, adding to landed cost. Packaging type, secondary containment, and handling certification (e.g., Cleanroom packaging for some electronics applications) differentially impact price tiers.
Global Market Analysis & Price Trends
Global Supply & Demand Overview
Market adoption of 1,3-dihydroxyadamantane is tied to specialty polymers, advanced coatings, and select pharmaceutical intermediates. The supply chain remains moderately consolidated with a few direct-process manufacturers. Periodic tightness follows both raw material disruptions and increases in downstream user demand, especially in electronics and specialty resins.
Key Economies Analysis
United States: Domestic supply focuses on high-purity, pharma-intermediate use; users prioritize traceability and multi-vendor qualification.
European Union: Compliance-led demand for REACH-registered shipments; multi-step documentation burdens lead to longer qualification cycles.
Japan: Quality and consistency take precedence; extensive validation periods often precede bulk uptake.
India: Cost efficiency and flexibility of lot size are more common purchase drivers; supply is exposed to global feedstock fluctuations.
China: Local manufacturers leverage proximity to raw materials; policy-shift-induced plant shutdowns can sharply restrict output, escalating prices or creating temporary shortages.
2026 Price Trend Forecast
Absent massive supply chain disruptions, global average pricing for standard grades may experience moderate escalation, led by the ongoing tightening of environmental controls on precursors and growing specialty applications. High-purity and custom-certified grades will likely see above-average increases, due to more costly process control and compliance with transnational regulatory structures. Price differentials by region will likely remain, with North America and EU maintaining the highest delivered costs due to compliance requirements and lower pricing in China/India driven by local manufacturing cost advantages.
Data Sources & Methodology
Market projections integrate in-house production data, key raw material price tracking, feedback from long-term industry partners, and regulatory update monitoring. Wherever grades diverge, trend analysis segments by application and region, crosschecked against port statistics and published trade flows. Global downstream demand data are synthesized from market studies conducted by recognized industry analysts.
Industry News & Regulatory Updates
Recent Market Developments
Plant shutdowns driven by stricter environmental audits in China during 2023-2024 substantially reduced spot market availability, intensifying price volatility. New entrants in India moved quickly to fill export demand, but initial lot rejection rates were higher due to process ramp-up challenges.
Regulatory Compliance Updates
Expanded regulatory scrutiny from EU and Japanese agencies has driven demand for more granular batch documentation, residue analysis, and complete impurity tracking. Updated material registration protocols, particularly for imported lots, now impact lead times and validation costs for downstream users. Revised requirements for operator safety and emission monitoring in production zones require ongoing process adaptation in manufacturing plants.
Supplier Response & Mitigation
To retain supply consistency, our plant operations have expanded the real-time analysis of feedstock purity and adopted flexible multi-source procurement. Ongoing investment in waste minimization and advanced neutralization of process effluents supports alignment with compliance trends in destination markets. Final release only occurs after multi-batch QA reconciliation and trace verification for international shipment lots. Supply contracts with critical users are now often tied to dynamic pricing clauses and co-managed risk reserves, offsetting raw material spikes or forced outages.
Application Fields & Grade Selection Guide for 1,3-Dihydroxyadamantane
Industry Applications
1,3-Dihydroxyadamantane functions as a core intermediate and functional additive in several segments: polymer modification, pharmaceutical intermediates, advanced coatings, and specialty resins. Each field imposes distinct standards based on end-use, degree of reactivity, and downstream regulatory exposure.
- Polymer and Resin Modification: Commonly introduced for cross-linking, thermal stability, or controlled release matrix applications. Polymer formulators focus on hydroxyl content and batch homogeneity for predictable reactivity and physical performance.
- Pharmaceutical Synthesis: Used as an intermediate for API or fine chemical synthesis routes demanding tight impurity control. Regulatory environments shape both allowable impurity profiles and documentation requirements.
- Coating and Adhesive Additives: Applied as a backbone modifier for improved hardness, abrasion resistance, or solubility. For waterborne systems, solubility and residual ionics draw attention; for solventborne, color and odor matter more.
- Electronics and High-Purity Applications: Demands for ultra-low metal or ionic contaminants intensify, since trace elements affect dielectric properties and device performance.
Grade-to-Application Mapping
| Industry Application | Recommended Grade | Key Grade-Dependent Parameters |
|---|---|---|
| Polymer/Resin Modification | Industrial Grade, Technical Grade | Hydroxyl purity, trace organic impurities |
| Pharmaceutical Synthesis | Pharma Grade | Organic residuals, specific identified impurities, microbiological screen |
| Coatings/Additives | Technical Grade, Special-Purpose Grade | Color index, residual solvents, low chloride/ionic content |
| Electronics/Semiconductors | High-Purity Electronics Grade | Ultra-low metals, particle count, sub-ppm ionic contamination |
Key Parameters by Application
Production scale and downstream application drive final property specification. For plastics and resins, consistency between batches ensures physical uniformity in the finished article. In the pharmaceutical sector, not only absolute purity but documented traceability and impurity identification rise to the fore. Additive use in coatings stresses physical appearance and volatility controls. High-purity electronics customers often specify analytical reports per batch for metal ions, each requiring routine and validated instrumental analysis.
How to Select the Right Grade
Step 1: Define Application
Clarify the function required—reactive intermediate, additive, or component matrix—since each function sets different benchmarks for purity, physical profile, and documentation. Early-stage specification benefits from a technical dialog with the manufacturer to avoid under- or over-specifying.
Step 2: Identify Regulatory Requirements
Regulatory frameworks for consumer goods, allied health, electronics, and coatings differ significantly. Product grade selection should align with local and international standards reflecting end-market: Good Manufacturing Practice (GMP) for pharmaceuticals, REACH or RoHS for electronics, or national chemical registrations. Non-compliance can result in costly delays or batch rejections.
Step 3: Evaluate Purity Needs
Not all processes tolerate the same impurity profile. Technical grade favors acceptable levels for industrial use but may not satisfy high-spec pharmaceutical or electronic lines. Purity is shaped by process route, in-process control, and post-synthesis purification—each contributing to final specification. Wherever possible, request analytical summary on key parameters (hydroxyl content, trace organic residues, residual metals) before major production runs.
Step 4: Consider Volume & Budget
Volume commitment affects supply chain planning and batch strategy. High-volume industrial applications may opt for a less stringently refined grade suited for compounding, while specialty markets demand smaller, tightly controlled lots. Pricing reflects both purification cost and downstream compliance. Detailed application data can help the production department recommend an appropriate cost-performance balance.
Step 5: Request Sample for Validation
Before confirming volume orders, request a representative sample for in-house or third-party validation. Assess actual physical and chemical properties against anticipated process criteria. Many properties—such as moisture stability, reactivity in target conditions, or solubility in chosen solvents—cannot be fully predicted from a datasheet alone.
Production and Grade Control Perspectives
Raw Material Selection
Selecting precursor materials influences purity potential and impurity distribution. The sourcing team reviews supplier documentation and incoming quality. For high-grade material, stricter acceptance thresholds for metals and halides apply. Commodity or bulk routes may tolerate broader ranges.
Process Route Selection
Process selection—be it batch or continuous—balances raw material cost, throughput, and yield. Pharma and electronics lines often use closed or inert systems with additional purification, minimizing cross-contamination. Technical grades utilize streamlined procedures with routine sampling.
Key Control Points
Consistent conversion, completeness of reaction, and removal of process-related by-products all depend on tightly managed reactor conditions. Skilled operators track time–temperature profiles, dosing precision, and pH/solvent management. Out-of-specification readings prompt review and, if needed, rework.
Impurity Management
Impurity profile reflects both the chemical route and the effectiveness of refining. Distillation, crystallization, or reprecipitation remove gross contaminants, though trace organic or inorganic residues fluctuate based on process history. Release limits align to grade and customer specs.
Batch Consistency
Batch-to-batch reproducibility relies on process automation and internal analytical testing. Every batch receives at least core property analysis: melting range, major impurity identification, and moisture check. Special grades see advanced analysis—elemental screening, microbiology, particle analysis per customer need.
Release Criteria
Finished batches release only after multi-point QC signoff. The release panel varies by grade: basic physical checks for technical grade, full compendial testing for pharma grade, metals and particle screening for electronics grade. The final release standard derives from internal criteria and, on request, customer-supplied standards. Ongoing stability monitoring supports long-term customer application success.
Trust & Compliance: Quality Certifications & Procurement Support for 1,3-Dihydroxyadamantane
Quality Compliance & Certifications
Quality Management Certifications
Quality assurance for 1,3-Dihydroxyadamantane (1,3-DHA) starts with robust quality management systems grounded in internationally recognized standards. The manufacturing facility operates under a documented quality management framework aligned with ISO 9001. Internal audits routinely stress traceability, equipment calibration, and continuous process improvement. Documentation of deviations and corrective measures is maintained as part of batch records.
For chemical plants manufacturing specialty cyclic alcohols, upstream quality stems from R&D-driven process qualification, aligning each production campaign’s risk profile with customer and regulatory criteria. Key inputs and consumables follow a vendor qualification program, eliminating undocumented supply sources. Each 1,3-DHA release reflects transparent lot history and in-process verification steps, not only end-testing.
Product-Specific Certifications
The certification suite for 1,3-Dihydroxyadamantane extends beyond basic COA issuance. Food, pharma, or electronic grades may require additional documentation reflecting relevant legal and industry requirements such as GMP, low-biotin, heavy metal, or specific halogen testing. For technical and industrial grades, impurity and moisture profiles are controlled to meet downstream stability or compatibility targets, which may be detailed in customer agreements. If a regulatory region demands REACH registration or a similar dossier, the compliance status is available for reference during onboarding.
Documentation & Reports
Each lot of 1,3-DHA leaves the plant with an analytical report correlating with internal reference standards. Batch-specific COAs include test methods used and specification limits unique to each grade. Documentation packages for audit or qualification purposes can also include raw material origin records, process flow diagrams, and impurity tracking reports from validation efforts. Chromatographic purity, polymorph distribution, and trace solvent levels appear by agreement for specialized end uses. Stability statements or change notifications are provided reactively to support ongoing supply chain qualification.
Purchase Cooperation Instructions
Stable Production Capacity Supply and Flexible Business Cooperation Plan
Reliable delivery of 1,3-Dihydroxyadamantane depends on both process scale and consistent raw material sourcing. Production scheduling considers both standard batch volume and the flexibility to adjust for heightened demand, product customization, or unplanned downtime. Supply agreements can structure offtake with rolling forecasts, buffer inventory, or supply-on-demand models, reducing end-user inventory burdens. Technical and commercial teams evaluate procurement risks together, offering volume-based supply guarantees or reservation options, especially for critical applications in pharmaceuticals or electronics.
Core Production Capacity and Stable Supply Capability
Manufacturing lines for 1,3-DHA are sized to accommodate both campaign and continuous production schemes. Equipment qualification ensures batch-to-batch reproducibility, with a focus on critical operations such as controlled hydroxylation and purification steps. Production output scales based on grade-specific requirements, whether aiming for bulk technical use or high-purity applications. Consistency is maintained via real-time analytics, process automation, and inventory management tailored to customer logistics windows.
Sample Application Process
Sample provision supports customer R&D and pre-qualification efforts. Typical sample requests proceed through technical evaluation for compatibility with downstream processes. Priority is set by intended use, required documentation, and compliance alignment. The request workflow records sample origin, lot data, and analytical package details, and customer feedback is looped into future production adjustments if necessary.
Detailed Explanation of Flexible Cooperation Mode
For long-term partnerships, business arrangements expand to include toll manufacturing, customized impurity profiling, consignment stock in customer facilities, or tailored packaging to streamline transfer into end-use processes. Commercial discussions factor in application volatility, evolving regulatory landscapes, and downstream performance data from customer sites. Where projects show volatility in volume requirements, contract terms allow for periodic adjustment. The technical support team maintains open channels throughout supply, coordinating quickly in the event of formulation changes, batch investigations, or urgent logistical shifts.
Market Forecast & Technical Support System for 1,3-Dihydroxyadamantane
Research & Development Trends
Current R&D Hotspots
Development teams are focusing on refining synthetic routes for 1,3-dihydroxyadamantane to increase batch yield consistency and reduce impurity profiles, especially tertiary alcohol byproducts that complicate downstream purification. Upstream selection of adamantane feedstock with defined impurity cutoffs and controlled oxygenation steps largely determines outgoing purity. The focus now rests on minimizing energy consumption during hydroxylation and solvent recovery, as regulatory pressures on process emissions tighten.
On the application side, the material’s rigidity and unique molecular symmetry continue to attract attention in catalysis and high-performance polymer modification. Test labs closely monitor the influence of minor isomer contamination on polymer performance. In-house analytics teams are studying how specific impurity types—arising from various hydroxylation catalysts—can disrupt key downstream reactions in electronics and resin sectors.
Emerging Applications
Technical groups in resins and coatings are investigating how the product’s diol function supports crosslinking and thermal stability in specialty polyesters and epoxy modifiers. Researchers in pharmaceutical intermediates assess its performance as a building block for complex rigid scaffolds. Engineering plastics manufacturers are evaluating the compound’s potential as a structure-directing agent due to its dense adamantane core.
Limited but ongoing work analyzes the use of 1,3-dihydroxyadamantane in solid-state electrolytes for batteries, where moisture uptake and migration resistance are vital. Application outcome is often grade-sensitive: moisture, particle size, and residual solvent content define successful incorporation and handling.
Technical Challenges & Breakthroughs
Production teams report that uniform dihydroxylation without overoxidation still presents yield losses close to grade specification thresholds. Continuous process optimization targets lower byproduct formation to simplify downstream crystallization and cut solvent recycling costs. Major breakthroughs arise from employing heterogeneous catalysts to avoid heavy-metal residues and lower waste treatment loads.
Monitoring methodologies have advanced, enabling on-line purity checks for lot release. Effective impurity rejection now hinges on in-process control at the oxidation and workup stages, with dedicated QC protocols benchmarked to customer spec rather than relying only on industry-average cutoffs.
Future Outlook
Market Forecast (3-5 Years)
Demand patterns over the next several years will largely track the expansion of high-performance polymers and specialty resins segments, where precise molecular architecture remains a purchasing focus. Customers are requesting lot-level analytical dossiers and certificate of analysis data that go beyond generic content to include isomer ratio and trace residuals reflective of their intended technical requirements.
Regional adoption curves differ: electronics and composites sectors in East Asia emphasize product consistency and batch traceability; European buyers are setting expectations for solvent and catalyst residue control. The market is accordingly trending toward high-purity, grade-specific variants with support for process customization.
Technological Evolution
Internal process groups continue to shift toward catalyst systems that offer selective hydroxylation with fewer environmental and purification burdens. Closed-loop solvent management, combined with real-time quality monitoring, has started to define batch reproducibility standards. Technicians are adopting digitally controlled process windows instead of relying on fixed timings or traditional titration endpoints, reducing batch-to-batch variability.
Downstream users expect material compatibility data tied to their own scaling and formulation conditions, so manufacturer application support now frequently includes joint pilot trials, additive compatibility studies, and custom packaging sizes to ensure safe, clean delivery for automated feed systems.
Sustainability & Green Chemistry
Process design focuses on reducing solvent loads and waste streams, replacing traditional oxidants with alternatives that lower overall effluent treatment requirements. Waste minimization strategies include reprocessing off-spec batches and valorizing byproduct streams where feasible. Selection of greener reagents and catalysts forms part of ongoing audits under ISO and regional regulatory frameworks.
Sustainability targets integrate with raw material selection by giving preference to suppliers offering documented green feedstock sourcing and minimized logistics footprints. Emissions and waste reporting follow a batch-centric approach, with full traceability from initial charging through to final packaging and dispatch.
Technical Support & After-Sales Service
Technical Consultation
Technical service chemists remain on-hand to interpret analytical data and advise application engineers on grade selection for targeted process windows. Routine support covers solubility guidance, impurity mapping, and formulation troubleshooting, all based on actual lot testing. Process-specific consultation often details impurity impact and storage stability under customer-defined handling regimes.
Application Optimization Support
Direct manufacturer support includes on-site visits for critical application launches, pilot-scale blending studies, and tailored impurity fingerprinting requested by formulators. Staff engage directly in method transfer, packaging revision, and supply chain tracing to reduce end-user nonconformance risk. Application teams help adapt storage and handling protocols to reflect both typical and high-stress transportation or outdoor storage scenarios.
For customers in advanced composites or pharmaceuticals, the technical support line addresses compatibility of delivered product with customer reactors, blending equipment, and in-line analytical instrumentation. Feedback cycles with R&D partners track new impurity trends and share process adjustment guidance based on the latest manufacturing data.
After-Sales Commitment
Every released lot carries a release profile supported by internal quality oversight, with requalification programs based on shelf life and storage tests under standard and customer-nominated conditions. Customer feedback on any technical deviation triggers an immediate cross-department review, including sampling, retesting, and corrective action if needed.
Ongoing after-sales service covers re-certification, documentation revision, and product stewardship updates depending on regulatory evolution. All technical responses remain traceable to original batch records, supply chain mapping, and specification review, ensuring customers can rapidly secure complete CQA/CQC files upon request.
Reliable Supply of 1,3-Dihydroxyadamantane from Direct Production
Manufacturers across coatings, adhesives, specialty polymers, and advanced materials sectors demand predictability. Our plant delivers 1,3-Dihydroxyadamantane as a consistent, fully controlled intermediate, engineered with critical attention to purity and particle size. Each batch adheres to our established production protocols, built on years of experience synthesizing complex adamantane derivatives at industrial scale.
Controlled Production—No Outsourcing, No Guesswork
Our operations manage the entire process on site—from raw material input to finished product. We invest in closed-system reactors, real-time analytics, and experienced personnel who track and optimize every synthesis step. Batch records are retained for traceability, enabling full accountability with each shipment. Our quality assurance team runs full suite assays and impurity profiling on every lot before release.
Industrial Roles for 1,3-Dihydroxyadamantane
Formulators in the resin and thermoset industry use our product for crosslinkers. Its rigid cage structure translates into thermal stability and chemical resistance for end products like coatings and adhesives. Electronics manufacturers integrate our material into key performance polymers for dielectric components. Research teams at pilot and production scale rely on our supply to launch new specialty applications targeted at next-generation solvent systems, hydrophobic modifiers, and biomedical carriers.
Packaging and Supply Reliability
We maintain dedicated filling lines and automated weighing to prevent handling cross-contamination. 1,3-Dihydroxyadamantane ships direct from our plant in custom-lined drums and high-density sacks engineered to preserve product integrity during storage and transit. Orders range from laboratory quantities to multi-ton consignment arrangements, shipped under confirmed packing protocols that match both domestic and overseas regulatory requirements. Inventory is structured to meet scheduled supply programs for uninterrupted manufacturing.
Technical Support—Backed by in-plant Knowledge
Unlike remote resellers, our team comprises process chemists and application engineers who work where the product is made. We support customer integration by providing firsthand knowledge of our 1,3-Dihydroxyadamantane’s compatibility with solvents, cure profiles, and downstream processing conditions. Scale-up support and troubleshooting stem from direct production experience, not distributed third-party data sheets.
Enabling Value for Industry Teams
Procurement managers and production planners gain a predictable lead time and batch repeatability. Distributors leverage our reliable volume commitments and factory pricing structures. Technical managers benefit from the transparency of single-source manufacturing—no hidden intermediaries, no shifting batch histories. Our supply chain model reduces risk and administrative overhead by streamlining all stages from synthesis to post-delivery support.
Industrial FAQ
What is the chemical purity and typical impurity profile of 1,3-Dihydroxyadamantane as supplied?
Production Standards and Purity Insights
In our manufacturing facility, 1,3-Dihydroxyadamantane receives the same controlled attention we dedicate to every specialty intermediate leaving our reactors. We focus on batch consistency and a purity standard that meets or exceeds 98 percent by gas chromatography. Maintaining material within that specification requires tight process monitoring during the adamantane hydroxylation stage and an unbroken chain of in-process controls from start to finish.
Downstream users in coatings, electronics, or pharmaceutical sectors want minimal interference from side products and a predictable impurity footprint. Our QC lab screens every lot using calibrated analytical instruments, including HPLC and GC-MS, to identify and quantify trace impurities. We enforce action thresholds for unidentified peaks and carry out root cause investigations if levels deviate.
Key Impurities and Their Control
Based on how 1,3-Dihydroxyadamantane forms, the most common byproducts come from incomplete hydroxylation or over-oxidation at the adamantane core. You may find traces of mono-hydroxyadamantane or other polyhydroxylated derivatives in low ppm ranges. Structural analogs like 1,3,5- or 1,3,7-trihydroxyadamantane remain undetectable in well-controlled lots, but we continue measuring for them given their potential to impact downstream catalysis or material performance.
Residual solvents from our final crystallization and drying stages sometimes appear below 0.1 percent, well below thresholds for most industrial and synthesis applications. We use analytical grade glycol solvents or water, depending on the application, and purge thoroughly during drying. Moisture content routinely measures under 0.5 percent by Karl Fischer titration. All certificates of analysis report trace solvent and water levels so users can decide if further drying or purification is required for their application.
Customer-focused Material Release Practices
Every outgoing drum or pail passes through release checks, including melt point, GC area normalization for main component, and impurity profiling. We maintain full batch retention samples and keep chromatograms on file for several years. Such retention not only enables quick response to out-of-spec events, but also supports traceability for regulated markets.
Feedback from high-end electronic and pharma customers pushed us to adopt more sensitive impurity detection and enforce even stricter acceptance limits. That drove investments into finer column technologies and extra sample cleanup steps. The result for users: each consignment matches or surpasses industry norms for high-purity intermediates.
Solutions to Common Impurity Concerns
If a process needs 1,3-Dihydroxyadamantane with even lower impurity thresholds, our technical team can discuss custom purification. We run pilot purification using preparative chromatography or additional recrystallization, guided by the impurity profile of the target batch. This hands-on approach suits R&D and small-scale production teams concerned with unknown side reactions or byproduct sensitivities.
From synthesis scale-up to delivery, we believe in open technical disclosure and collaboration. Material data sheets and batch-level CoAs are available for all shipments, with impurity profiles reported against our validated analytical methods. Our customers’ production reliability starts with input consistency—and everything about our impurity control reflects that focus on what real-world manufacturers value.
What is the minimum order quantity and lead time for bulk procurement of 1,3-Dihydroxyadamantane?
Bulk buyers of 1,3-Dihydroxyadamantane come to us expecting clarity on order requirements and delivery timeframes. Our factory operation is structured around controlled batch production. This means minimum order quantities are not set arbitrarily but based on what ensures stable quality, production efficiency, and logistics safety. For this product, we define our minimum order quantity at 200 kilograms per batch. Experience shows that this threshold optimizes reactor yields, raw material use, and packaging schedules while preventing operational dead stock.
We keep our plant set up for batch runs, with clear timelines formed from raw material sourcing, synthesis, purification, and packing. Each production run begins only after comprehensive quality analysis on inputs. For orders at or above our base MOQ, standard lead time runs between four and six weeks from receipt of purchase commitment. This window covers raw material checks, reactor operation, filtration, multiple crystallization steps, and full analytical release testing. Certain seasons, specialty packaging requests, or shifts in upstream supply can affect this schedule. If demand spikes, or projects involve custom specifications, our technical team alerts buyers early about revised timelines.
We base our consistent lead time on decades of plant development, modernized production lines, and chemical engineering practices. Raw material approvals and full-traceability are available. Every batch is validated with spectral, chromatographic, and purity tests before packing. Warehouse staging is managed for efficient batch segmentation and prompt shipping after certificates of analysis confirm product consistency. For qualified buyers with ongoing needs, we maintain a supply schedule supported by rolling contracts. This approach ensures 1,3-Dihydroxyadamantane supply remains stable, and mitigates the risk of interruption due to outages in upstream reagents or logistics bottlenecks.
Bulk procurement by serious end-users often brings up concerns about continuity and quality traceability. We retain complete sample retentions and batch data to support post-delivery questions. With experience supplying to pharmaceuticals, advanced materials, and specialty chemical sectors, we’ve found close alignment between open production communication and trust in supply reliability. Clients receive transparency in lead times, real-world manufacturing calendars, and direct technical access to address application questions.
For those evaluating whether our MOQ and lead times fit their production lines, we encourage up-front technical discussions. Our plant can handle volume-based scale-ups and longer-term agreements, which sometimes enable priority production slots for strategic partners. Flexibility for packaging, including steel drums or composite bags, is coordinated with customers before the production cycle. We always provide documentation for hazard compliance, customs clearance, and on-request, full analytical certificates with each bulk shipment.
In a market where reliability, predictability, and batch integrity drive choice, our factory operates with established process controls. Our minimum order quantity and lead time stand as a reflection of what’s proven practical, quality-driven, and scalable—not temporary policy. By managing every step internally, from controlled procurement of raw materials to finished-goods inspection in our own labs, we support our buyers’ own business continuity. Those supply chain standards are our everyday practice, not an afterthought.
Are there any specific shipping, handling, or regulatory requirements for transporting 1,3-Dihydroxyadamantane internationally?
Moving 1,3-Dihydroxyadamantane across international borders presents distinct challenges tied closely to its chemistry and the shifting regulatory landscape. From our production plant to end users worldwide, each shipment brings hands-on experience with the physical nature of this specialty chemical alongside strict attention to transport legislation.
Practical Realities of Shipping 1,3-Dihydroxyadamantane
Our production process emphasizes purity for consistent performance across all applications. Yet, after packaging, the focus swiftly turns to international shipping standards. Temperature and moisture control remain pivotal for 1,3-Dihydroxyadamantane. The material, as produced in our reactors, remains stable under standard conditions, but exposure to excessive moisture or heat during transit can introduce risks to its integrity. We select sealed containers and robust moisture barriers to guard against ambient humidity, particularly for ocean freight. Dry, cool storage environments, supported by real-time temperature loggers in containers, help maintain material quality from factory dispatch to customer site.
We always document batch traceability and offer full batch documentation with every outgoing shipment, not only to reassure our customers but to provide clear evidence of compliance should customs or destination regulators request verification. Our material safety data and transport documentation are accessible in multiple languages where export activities dictate demand.
Regulatory and Customs Compliance
International transit of chemical products carries a patchwork of local, regional, and global requirements. 1,3-Dihydroxyadamantane does not appear on lists of controlled precursors or on major international restricted chemical lists. Our compliance team continuously monitors updates from agencies, including the European Chemicals Agency (ECHA), US Environmental Protection Agency (EPA), and relevant Asian and South American authorities.
1,3-Dihydroxyadamantane generally moves under standard shipping codes because it is neither classified as a hazardous substance under the UN model regulations nor does it carry specific REACH registration constraints at normal shipment volumes. Nonetheless, we never cut corners with paperwork. We include accurate Harmonized System (HS) codes, supply comprehensive safety and handling instructions, and pre-file required documents to avoid clearance delays. Customer projects with unique requirements—such as higher purity grades or bulk volumes—tap into our export documentation service, which supports full transparency and predictable delivery schedules.
Handling at Scale: Lessons from the Factory Floor
As a direct manufacturer, we maintain responsibility for worker safety and environmental protection from the reactor vessel through storage and export. Standard facility rules—use of appropriate chemical-resistant gloves, splash goggles, and containment controls—extend into our loading operations. For significant shipments, we work with carriers trained specifically in chemical logistics, ensuring container sealing and manifest checks during handoff. We treat external logistics partners as collaborative extensions of our manufacturing environment—periodic reviews, in-person audits, and clear escalation channels guard against any lapses that could affect product safety, compliance, or reputation.
Shipping Solutions and Future Improvements
We continually inspect and update our packaging systems, and we invest in palletization and strapping methods that cut down the risk of in-transit damage. In response to customer suggestions and regulatory updates, our technical team is evaluating advanced desiccant systems for extended sea shipments and exploring new track-and-trace technologies. These improvements help us offer reliable delivery worldwide, giving partners in research, specialty synthesis, and industry the confidence that every consignment of 1,3-Dihydroxyadamantane arrives with the quality and compliance they expect from a direct manufacturer.
Technical Support & Inquiry
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327